Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Jan;105(1):181–183. doi: 10.1111/j.1476-5381.1992.tb14232.x

Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs.

M F Poncet 1, C Damase-Michel 1, G Tavernier 1, M A Tran 1, M Berlan 1, J L Montastruc 1, P Montastruc 1
PMCID: PMC1908632  PMID: 1596679

Abstract

1. Plasma levels of noradrenaline (NA) and neuropeptide Y (NPY) were evaluated in two experimental models associated with an increase in sympathetic tone: conscious dogs which were subject to either sinoaortic denervation or acute administration of the alpha 2-adrenoceptor antagonist yohimbine. 2. Dogs that had undergone sinoaortic denervation exhibited a two fold increase in plasma NA without any change in NPY levels. 3. Yohimbine (0.05 mg kg-1 i.v. as a bolus) produced similar effects. A higher dose of yohimbine (0.5 mg kg-1 i.v.) increased both plasma NA (7 fold) and NPY (6.5 fold) levels. 4. The present results indicate that changes in plasma catecholamines and NPY are not always concomitant. They suggest that the simultaneous release of NA and NPY is only observed under in vivo conditions for a marked increase in sympathetic tone.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. M., Bircham P. M., Bloom S. R., Edwards A. V. Release of neuropeptide Y in response to splanchnic nerve stimulation in the conscious calf. J Physiol. 1984 Dec;357:401–408. doi: 10.1113/jphysiol.1984.sp015507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Briand R., Yamaguchi N., Gagne J., Nadeau R., de Champlain J. Alpha 2-adrenoceptor modulation of catecholamine and neuropeptide Y responses during haemorrhagic hypotension in anaesthetized dogs. J Auton Nerv Syst. 1990 Jun;30(2):111–122. doi: 10.1016/0165-1838(90)90134-5. [DOI] [PubMed] [Google Scholar]
  3. Castagné V., Corder R., Gaillard R., Mormède P. Stress-induced changes of circulating neuropeptide Y in the rat: comparison with catecholamines. Regul Pept. 1987 Oct;19(1-2):55–63. doi: 10.1016/0167-0115(87)90074-7. [DOI] [PubMed] [Google Scholar]
  4. Dahlöf C., Dahlöf P., Lundberg J. M. Alpha 2-adrenoceptor-mediated inhibition of nerve stimulation-evoked release of neuropeptide Y (NPY)-like immunoreactivity in the pithed guinea-pig. Eur J Pharmacol. 1986 Nov 19;131(2-3):279–283. doi: 10.1016/0014-2999(86)90583-2. [DOI] [PubMed] [Google Scholar]
  5. Damase-Michel C., Valet P., Montastruc J. L. Nicardipine causes sympathetic activation that does not involve baroreceptor reflex tachycardia in conscious sinoaortic-denervated dogs. Eur J Pharmacol. 1987 Oct 6;142(1):145–149. doi: 10.1016/0014-2999(87)90665-0. [DOI] [PubMed] [Google Scholar]
  6. Goldberg M. R., Robertson D. Yohimbine: a pharmacological probe for study of the alpha 2-adrenoreceptor. Pharmacol Rev. 1983 Sep;35(3):143–180. [PubMed] [Google Scholar]
  7. Hjemdahl P. Plasma catecholamines as markers for sympatho-adrenal activity in human primary hypertension. Pharmacol Toxicol. 1988;63 (Suppl 1):27–31. doi: 10.1111/j.1600-0773.1988.tb02034.x. [DOI] [PubMed] [Google Scholar]
  8. Howe P. R., Rogers P. F., Morris M. J., Chalmers J. P., Smith R. M. Plasma catecholamines and neuropeptide-Y as indices of sympathetic nerve activity in normotensive and stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1986 Nov-Dec;8(6):1113–1121. doi: 10.1097/00005344-198611000-00004. [DOI] [PubMed] [Google Scholar]
  9. Hulting J., Sollevi A., Ullman B., Franco-Cereceda A., Lundberg J. M. Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure. Cardiovasc Res. 1990 Feb;24(2):102–108. doi: 10.1093/cvr/24.2.102. [DOI] [PubMed] [Google Scholar]
  10. Lundberg J. M., Franco-Cereceda A., Hemsén A., Lacroix J. S., Pernow J. Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)-mediated sympathetic cotransmission. Fundam Clin Pharmacol. 1990;4(4):373–391. doi: 10.1111/j.1472-8206.1990.tb00692.x. [DOI] [PubMed] [Google Scholar]
  11. Lundberg J. M., Martinsson A., Hemsén A., Theodorsson-Norheim E., Svedenhag J., Ekblom B., Hjemdahl P. Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun. 1985 Nov 27;133(1):30–36. doi: 10.1016/0006-291x(85)91837-6. [DOI] [PubMed] [Google Scholar]
  12. Lundberg J. M., Rudehill A., Sollevi A., Fried G., Wallin G. Co-release of neuropeptide Y and noradrenaline from pig spleen in vivo: importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport. Neuroscience. 1989;28(2):475–486. doi: 10.1016/0306-4522(89)90193-0. [DOI] [PubMed] [Google Scholar]
  13. Morris M. J., Russell A. E., Kapoor V., Cain M. D., Elliott J. M., West M. J., Wing L. M., Chalmers J. P. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man. J Auton Nerv Syst. 1986 Oct;17(2):143–149. doi: 10.1016/0165-1838(86)90089-5. [DOI] [PubMed] [Google Scholar]
  14. Pernow J., Lundberg J. M., Kaijser L. Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans. J Cardiovasc Pharmacol. 1988;12(5):593–599. doi: 10.1097/00005344-198811000-00014. [DOI] [PubMed] [Google Scholar]
  15. Solt V. B., Brown M. R., Kennedy B., Kolterman O. G., Ziegler M. G. Elevated insulin, norepinephrine, and neuropeptide Y in hypertension. Am J Hypertens. 1990 Nov;3(11):823–828. doi: 10.1093/ajh/3.11.823. [DOI] [PubMed] [Google Scholar]
  16. Ullman B., Franco-Cereceda A., Hulting J., Lundberg J. M., Sollevi A. Elevation of plasma neuropeptide Y-like immunoreactivity and noradrenaline during myocardial ischaemia in man. J Intern Med. 1990 Dec;228(6):583–589. doi: 10.1111/j.1365-2796.1990.tb00283.x. [DOI] [PubMed] [Google Scholar]
  17. Valet P., Damase-Michel C., Montastruc J. L., Montastruc P. Plasma catecholamines and adrenoceptors after chronic sinoaortic denervation in dogs. Fundam Clin Pharmacol. 1989;3(3):307–320. doi: 10.1111/j.1472-8206.1989.tb00459.x. [DOI] [PubMed] [Google Scholar]
  18. Valet P., Montastruc J. L., Berlan M., Tran M. A., Lafontan M., Montastruc P. Differential regulation of fat cell beta-2 and beta-1 adrenoceptors by endogenous catecholamines in dog. J Pharmacol Exp Ther. 1989 Apr;249(1):271–277. [PubMed] [Google Scholar]
  19. Valet P., Taouis M., Tran M. A., Montastruc P., Lafontan M., Berlan M. Lipomobilizing effects of procaterol and yohimbine in the conscious dog: comparison of endocrinological, metabolic and cardiovascular effects. Br J Pharmacol. 1989 May;97(1):229–239. doi: 10.1111/j.1476-5381.1989.tb11946.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Zukowska-Grojec Z., Konarska M., McCarty R. Differential plasma catecholamine and neuropeptide Y responses to acute stress in rats. Life Sci. 1988;42(17):1615–1624. doi: 10.1016/0024-3205(88)90440-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES